# Baker Hughes Co: financial statements, quarterly

BKR · Nasdaq · CIK 1701605 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bkr.md) · [Financials](/companies/bkr/financials.md) · [Filings](/companies/bkr/filings.md) · [Insiders](/companies/bkr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bkr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,641](/filings/0001701605-24-000131.md) | [6,835 d](/filings/0001701605-26-000007.md) | [6,418](/filings/0001701605-25-000075.md) | [7,139](/filings/0001701605-25-000107.md) | [6,908](/filings/0001701605-25-000117.md) | [7,364 d](/filings/0001701605-26-000007.md) | [6,427](/filings/0001701605-26-000014.md) | [6,910](/filings/0001701605-26-000023.md) | [7,010](/filings/0001701605-25-000117.md) | [7,386 d](/filings/0001701605-26-000007.md) | [6,587](/filings/0001701605-26-000014.md) | [6,742](/filings/0001701605-26-000023.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | [164](/filings/0001701605-25-000075.md) | [158](/filings/0001701605-25-000107.md) | [158](/filings/0001701605-25-000117.md) | [163 d](/filings/0001701605-26-000007.md) | [146](/filings/0001701605-26-000014.md) | [161](/filings/0001701605-26-000023.md) | [146](/filings/0001701605-25-000117.md) | [147 d](/filings/0001701605-26-000007.md) | [133](/filings/0001701605-26-000014.md) | [143](/filings/0001701605-26-000023.md) |
| Selling, general and administrative | $m | [627](/filings/0001701605-24-000131.md) | [634 d](/filings/0001701605-26-000007.md) | [618](/filings/0001701605-25-000075.md) | [643](/filings/0001701605-25-000107.md) | [612](/filings/0001701605-25-000117.md) | [585 d](/filings/0001701605-26-000007.md) | [577](/filings/0001701605-26-000014.md) | [567](/filings/0001701605-26-000023.md) | [607](/filings/0001701605-25-000117.md) | [636 d](/filings/0001701605-26-000007.md) | [562](/filings/0001701605-26-000014.md) | [569](/filings/0001701605-26-000023.md) |
| Operating income | $m | [714](/filings/0001701605-24-000131.md) | [651 d](/filings/0001701605-25-000035.md) | [653](/filings/0001701605-24-000067.md) | [833](/filings/0001701605-24-000111.md) | [930](/filings/0001701605-24-000131.md) | [665 d](/filings/0001701605-25-000035.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [235](/filings/0001701605-24-000131.md) | [71.0 d](/filings/0001701605-26-000007.md) | [178](/filings/0001701605-25-000075.md) | [243](/filings/0001701605-25-000107.md) | [235](/filings/0001701605-25-000117.md) | [(399) d](/filings/0001701605-26-000007.md) | [152](/filings/0001701605-26-000014.md) | [256](/filings/0001701605-26-000023.md) | [204](/filings/0001701605-25-000117.md) | [(359) d](/filings/0001701605-26-000007.md) | [336](/filings/0001701605-26-000014.md) | [210](/filings/0001701605-26-000023.md) |
| Net income | $m | [518](/filings/0001701605-24-000131.md) | [440 d](/filings/0001701605-26-000007.md) | [455](/filings/0001701605-25-000075.md) | [579](/filings/0001701605-25-000107.md) | [766](/filings/0001701605-25-000117.md) | [1,179 d](/filings/0001701605-26-000007.md) | [402](/filings/0001701605-26-000014.md) | [701](/filings/0001701605-26-000023.md) | [609](/filings/0001701605-25-000117.md) | [876 d](/filings/0001701605-26-000007.md) | [930](/filings/0001701605-26-000014.md) | [681](/filings/0001701605-26-000023.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [16.2](/filings/0001701605-23-000078.md) | [16.3](/filings/0001701605-25-000035.md) | [16.4](/filings/0001701605-24-000067.md) | [15.9](/filings/0001701605-24-000111.md) | [16.6](/filings/0001701605-24-000131.md) | [17.2](/filings/0001701605-26-000007.md) | [16.8](/filings/0001701605-25-000075.md) | [17.6](/filings/0001701605-25-000107.md) | [17.5](/filings/0001701605-25-000117.md) | [18.8](/filings/0001701605-26-000023.md) | [28.6](/filings/0001701605-26-000014.md) | [30.6](/filings/0001701605-26-000023.md) |
| Total assets | $bn | [36.6](/filings/0001701605-23-000078.md) | [36.9](/filings/0001701605-25-000035.md) | [37.1](/filings/0001701605-24-000067.md) | [36.7](/filings/0001701605-24-000111.md) | [37.5](/filings/0001701605-24-000131.md) | [38.4](/filings/0001701605-26-000007.md) | [38.1](/filings/0001701605-25-000075.md) | [38.7](/filings/0001701605-25-000107.md) | [39.2](/filings/0001701605-25-000117.md) | [40.9](/filings/0001701605-26-000023.md) | [50.9](/filings/0001701605-26-000014.md) | [52.6](/filings/0001701605-26-000023.md) |
| Current liabilities | $bn | [12.7](/filings/0001701605-23-000078.md) | [13.0](/filings/0001701605-25-000035.md) | [13.2](/filings/0001701605-24-000067.md) | [12.6](/filings/0001701605-24-000111.md) | [12.8](/filings/0001701605-24-000131.md) | [13.0](/filings/0001701605-26-000007.md) | [12.6](/filings/0001701605-25-000075.md) | [12.5](/filings/0001701605-25-000107.md) | [12.4](/filings/0001701605-25-000117.md) | [13.9](/filings/0001701605-26-000023.md) | [13.4](/filings/0001701605-26-000014.md) | [14.6](/filings/0001701605-26-000023.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.8](/filings/0001701605-23-000078.md) | [0.1](/filings/0001701605-25-000035.md) | [0.1](/filings/0001701605-24-000067.md) | [0.0](/filings/0001701605-24-000111.md) | [0.1](/filings/0001701605-24-000131.md) | [0.1](/filings/0001701605-26-000007.md) | [0.1](/filings/0001701605-25-000075.md) | [0.1](/filings/0001701605-25-000107.md) | [0.1](/filings/0001701605-25-000117.md) | [0.7](/filings/0001701605-26-000023.md) | [0.8](/filings/0001701605-26-000014.md) | [0.8](/filings/0001701605-26-000023.md) |
| Shareholders' equity | $bn | [15.3](/filings/0001701605-23-000078.md) | [15.4](/filings/0001701605-25-000035.md) | [15.4](/filings/0001701605-24-000067.md) | [15.6](/filings/0001701605-24-000111.md) | [16.2](/filings/0001701605-24-000131.md) | [16.9](/filings/0001701605-26-000007.md) | [17.0](/filings/0001701605-25-000075.md) | [17.7](/filings/0001701605-25-000107.md) | [18.2](/filings/0001701605-25-000117.md) | [18.8](/filings/0001701605-26-000023.md) | [19.3](/filings/0001701605-26-000014.md) | [19.9](/filings/0001701605-26-000023.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [810 d](/filings/0001701605-24-000131.md) | [932 d](/filings/0001701605-26-000007.md) | [784](/filings/0001701605-25-000075.md) | [348 d](/filings/0001701605-25-000107.md) | [1,010 d](/filings/0001701605-25-000117.md) | [1,190 d](/filings/0001701605-26-000007.md) | [709](/filings/0001701605-26-000014.md) | [510 d](/filings/0001701605-26-000023.md) | [929 d](/filings/0001701605-25-000117.md) | [1,662 d](/filings/0001701605-26-000007.md) | [500](/filings/0001701605-26-000014.md) | [1,345 d](/filings/0001701605-26-000023.md) |
| Capital expenditure | $m | [281 d](/filings/0001701605-24-000131.md) | [356 d](/filings/0001701605-26-000007.md) | [333](/filings/0001701605-25-000075.md) | [292 d](/filings/0001701605-25-000107.md) | [300 d](/filings/0001701605-25-000117.md) | [353 d](/filings/0001701605-26-000007.md) | [300](/filings/0001701605-26-000014.md) | [301 d](/filings/0001701605-26-000023.md) | [295 d](/filings/0001701605-25-000117.md) | [377 d](/filings/0001701605-26-000007.md) | [336](/filings/0001701605-26-000014.md) | [300 d](/filings/0001701605-26-000023.md) |
| Dividends paid | $m | [202 d](/filings/0001701605-24-000131.md) | [200 d](/filings/0001701605-26-000007.md) | [210](/filings/0001701605-25-000075.md) | [209 d](/filings/0001701605-25-000107.md) | [209 d](/filings/0001701605-25-000117.md) | [208 d](/filings/0001701605-26-000007.md) | [229](/filings/0001701605-26-000014.md) | [227 d](/filings/0001701605-26-000023.md) | [227 d](/filings/0001701605-25-000117.md) | [227 d](/filings/0001701605-26-000007.md) | [228](/filings/0001701605-26-000014.md) | [228 d](/filings/0001701605-26-000023.md) |
| Share repurchases | $m | [120 d](/filings/0001701605-24-000131.md) | [319 d](/filings/0001701605-26-000007.md) | [158](/filings/0001701605-25-000075.md) | [166 d](/filings/0001701605-25-000107.md) | [152 d](/filings/0001701605-25-000117.md) | [8.0 d](/filings/0001701605-26-000007.md) | [188](/filings/0001701605-26-000014.md) | [196 d](/filings/0001701605-26-000023.md) | [0.0 d](/filings/0001701605-25-000117.md) | [0.0 d](/filings/0001701605-26-000007.md) | [0.0](/filings/0001701605-26-000014.md) | [0.0 d](/filings/0001701605-26-000023.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2020 (2020-06-30) | Q2 FY2021 (2021-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [655](/filings/0001701605-21-000087.md) | [806](/filings/0001701605-21-000087.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 992,674,071 at 2026-07-23, from the cover of the [10-Q filed 2026-07-27](/filings/0001701605-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.